Fractional change in apparent diffusion coefficient as an imaging biomarker for predicting treatment response in head and neck cancer treated with chemoradiotherapy

American Journal of Neuroradiology

Volumn 35, Issue 2, 2014, Pages 379-385

  Matoba, Munetaka ^a   Tuji, H ^a   Shimode, Y ^a   Toyoda, I ^a   Kuginuki, Y ^a   Miwa, K ^a   Tonami, H ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84894217260     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A3706     Document Type: Article

References (24)

1. Argiris A, Karamouzis MV, Raben D, et al. Head and neck cancer. Lancet 2008;371: 1695-709
2. Horiot JC, Bontemps P, van den Bogaert W, et al. Accelerated fractionation (AF) compared with conventional fractionation (CF) improves locoregional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol 1997;44: 111-21
3. Ang KK, Tortti A, Brown BW, et al. Randomized trial addressing risk feature and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001;51: 571-78
4. Chiesa F, Mauri S, Tradati N, et al. Surfing prognostic factors in head and neck cancer at the millennium. Oral Oncol 1999;35: 590-96
5. Chenevert TL, Stegman LD, Taylor JM, et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 2000;92: 2029-36
6. Kim S, Loevner L, Quon H, et al. Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res 2009;15: 986-94
7. Hatakenaka M, Nakamura K, Yabuuchi H, et al. Pretreatment apparent diffusion coefficient of the primary lesion correlates with local failure in head-and-neck cancer treated with chemoradiotherapy or radiotherapy. Int J Radiat Oncol Biol Phys 2011;81: 339-45
8. Vandecaveye V, Dirix P, De Keyzer F, et al. Predictive value of diffusion- weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma. Eur Radiol 2010;20: 1703-14
9. King AD, Mo FK, Yu KH, et al. Squamous cell carcinoma of the head and neck: diffusion-weightedMRimaging for prediction and monitoring of treatment response. Eur Radiol 2010;20: 2213-20
10. Vandecaveye V, Dirix P, Keyzer FD, et al. Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2012;82: 1098-107
11. Kato H, Kanematsu M, Tanaka O, et al. Head and neck squamous cell carcinoma: usefulness of diffusion-weighted MR imaging in the prediction of a neoadjuvant therapeutic effect. Eur Radiol 2009;19: 103-09
12. Hamstra DA, Rehemtulla A, Ross BD. Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology. J Clin Oncol 2007;25: 4104-09
13. Roth Y, Tichler T, Kostenich G, et al. High-b-value diffusionweighted MR imaging for pretreatment prediction and early monitoring of tumor response to therapy in mice. Radiology 2004; 232: 685-92
14. Hamstra DA, Lee KC, Moffat BA, et al. Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotheray in a mouse model of squamous cell cancer of head and neck. Transl Oncol 2008;1: 187-94
15. Padhani AR, Liu G, Koh DM, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009;11: 102-25
16. Moffat BA, Chenevert TL, Lawrence TS, et al. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci USA2005;102: 5524-29
17. Galbán CJ, Mukherji SK, Chenevert TL, et al. A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Transl Oncol 2009;2: 184-90
18. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007; 188: 1622-35
19. Chung EJ, Lee NJ, Baek SK, et al. Clinical efficacy of primary tumor volume measurements: comparison of different primary sites. Clin Exp Otorhinolaryngol 2009;2: 78-84
20. Pignon JP, Bourhis J, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet 2000; 355: 949-55
21. Lango MN, Myers JN, Garden AS. Controversies in surgical management of the node-positive neck after chemoradiation. Semin Radiat Oncol 2009;19: 24-28
22. Labadie RF, Yarbrough WG, Weissler MC, et al. Nodal volume reduction after concurrent chemo- and radiotherapy: correlation between initial CT and histopathologic findings. AJNR Am J Neuroradiol 2000;21: 310-14
23. Clavel S, Charron MP, Belair M, et al. The role of computed tomography in the management of the neck after chemoradiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys 2012;82: 567-73
24. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus: positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008;100: 261-69